American College of Physicians: Internal Medicine — Doctors for Adults ®


ACP Diabetes Monthly

Welcome to this month's issue of ACP Diabetes Monthly, an update for internists published by the American College of Physicians.

In the News for the month of November 2016


Short-term antiplatelet therapy after PCI appears better than long-term in patients with diabetes, meta-analysis finds

In patients with diabetes, long-term dual antiplatelet therapy (DAPT) was associated with a higher rate of major or minor bleeding compared with short-term DAPT, while the increase was nonsignificant in those without diabetes. More...

Medicare finalizes policies to expand its Diabetes Prevention Program Model

The intervention for Medicare beneficiaries with prediabetes includes at least 16 weekly hour-long sessions over months 1 to 6 and at least 6 monthly maintenance sessions over months 6 to 12. More...

Intervention with web-based component appears to raise hypoglycemia awareness

The blood glucose awareness training involved three 2.5-hour group sessions over 4 weeks plus 2 online modules to be done between group meetings. More...

Test yourself

MKSAP quiz: Exercise and hypoglycemia

This month's quiz asks readers to advise a 40-year-old man with type 1 diabetes who has intensified his exercise routine in preparation for participation in a 10-K race. More...

From ACP Journal Club

In type 2 diabetes treated with high-dose insulin, liraglutide reduced HbA1c

The hypoglycemia rate was higher in the first month after initiation of liraglutide, but the overall hypoglycemia rate over the 6-month follow-up was similar in liraglutide and placebo patients. More...

In patients with type 2 diabetes and high CV risk, liraglutide reduced a composite CV outcome at a median 3.8 y

The study's primary composite outcome was first occurrence of death from cardiovascular (CV) causes, nonfatal (including silent) myocardial infarction, or nonfatal stroke. More...

In patients with type 2 diabetes and CVD, empagliflozin reduced incident or worsening nephropathy at 3.1 y

A subanalysis of a trial of empagliflozin for patients with cardiovascular disease (CVD) found lower rates of nephropathy in those randomized to empagliflozin rather than placebo. More...

From ACP Internist Weekly

Weight loss program may improve HbA1c more than typical diabetes nutrition counseling, study finds

Patients participating in Weight Watchers program supplemented with diabetes education lost more weight than a control group by 3, 6, 9, and 12 months of follow-up. More...

Keeping tabs

Spotlight on activity

The American Diabetes Association (ADA) issued a new position statement on physical activity and exercise, and a recent study offered some additional advice on the topic. More...

Physician editor: David V. O'Dell, MD, FACP

About ACP Diabetes Monthly

ACP Diabetes Monthly is a monthly newsletter produced by the staff of ACP Internist. It is automatically sent to all College members who have an e-mail address on file with ACP.

To sign up for ACP Diabetes Monthly, please click here.

Copyright © by American College of Physicians.


Test yourself

A 24-year-old woman undergoes routine evaluation. She is pregnant at 12 weeks' gestation. Medical history is notable for homozygous sickle cell anemia (Hb SS). She has had multiple uncomplicated painful crises treated at home with hydration, nonopioid analgesia, and incentive spirometry. Following a physical exam and lab studies, what is the most appropriate management?

Find the answer

Not an ACP Member?

Join today and discover the benefits waiting for you.

Not an ACP Member? Join today and discover the benefits waiting for you

ACP offers different categories of membership depending on your career stage and professional status. View options, pricing and benefits.

A New Way to Ace the Boards!

A New Way to Ace the Boards!

Ensure you're board-exam ready with ACP's Board Prep Ace - a multifaceted, self-study program that prepares you to pass the ABIM Certification Exam in internal medicine. Learn more.